Combination delivery of Adjudin and Doxorubicin via integrating drug conjugation and nanocarrier approaches for the treatment of drug-resistant cancer cells-Reference-Cited by-同舟云学术

Combination delivery of Adjudin and Doxorubicin via integrating drug conjugation and nanocarrier approaches for the treatment of drug-resistant cancer cells

Published:2015 Issue:8 Volume:3 Page:1556-1564
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Li Xu¹²³⁴⁵,Gao Cuixia¹²³⁴⁵,Wu Yupei¹²³⁴⁵,Cheng C.-Yan⁶⁷⁸⁹¹⁰,Xia Weiliang¹¹¹²¹³¹⁴¹⁵,Zhang Zhiping¹²³⁴⁵

Affiliation:

1. Tongji School of Pharmacy

2. National Engineering Research Center for Nanomedicine

3. Huazhong University of Science and Technology

4. Wuhan 430030

5. P.R. China

6. The Mary M. Wohlford Laboratory for Male Contraceptive Research

7. Center for Biomedical Research

8. Population Council

9. New York

10. USA

11. State Key Laboratory of Oncogenes and Related Genes

12. Renji-Med X Clinical Stem Cell Research Center

13. Ren Ji Hospital

14. School of Medicine

15. School of Biomedical Engineering & Med-X Research Institute

Abstract

We integrate drug conjugation and nanocarrier approaches to co-deliver Adjudin and Doxorubicin for the treatment of drug-resistant cancer cells.

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2015/TB/C4TB01764A

Reference37 articles.

1. Cancer drug resistance: an evolving paradigm

2. Traceable Multifunctional Micellar Nanocarriers for Cancer-Targeted Co-delivery of MDR-1 siRNA and Doxorubicin

3. Co-delivery of Doxorubicin and Bcl-2 siRNA by Mesoporous Silica Nanoparticles Enhances the Efficacy of Chemotherapy in Multidrug-Resistant Cancer Cells

4. Co-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistance

5. P-glycoprotein silencing with siRNA delivered by DOPE-modified PEI overcomes doxorubicin resistance in breast cancer cells

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NIR-light-triggered delivery of doxorubicin-loaded PLGA nanoparticles for synergistic cancer therapy on DMBA/TPA induced tumor-bearing mice;Materials Advances;2023

2. A pH/temperature responsive nanocomposite for chemo-photothermal synergistic cancer therapy;Smart Materials in Medicine;2023

3. Tailoring carrier-free nanocombo of small-molecule prodrug for combinational cancer therapy;Journal of Controlled Release;2022-12

4. Oxidative Stress-Induced Silver Nano-Carriers for Chemotherapy;Pharmaceuticals;2022-11-22

5. Smart and eco-friendly N-isopropylacrylamide and cellulose hydrogels as a safe dual-drug local cancer therapy approach;Carbohydrate Polymers;2022-11